Heavier Agent Orange exposure tied to nearly double the Parkinson's risk in veterans
A review of health records for 4.9 million Vietnam-era veterans also found higher rates of Lewy body dementia, with the steepest risk among troops who sprayed the herbicide.

Vietnam-era veterans who sprayed or directly handled Agent Orange were 99% more likely to be diagnosed with Parkinson's disease than veterans with no exposure, according to a large study of veterans' health records published in JAMA Neurology.
The research was led by Oregon Health & Science University and the VA Portland Health Care System. It drew on electronic records covering 4.9 million veterans who served during the Vietnam War era. Elevated risk showed up even among veterans whose exposure was less certain. Those with possible or presumed exposure were 44% more likely to develop Parkinson's and 66% more likely to develop Lewy body dementia, a related brain disorder. Across both conditions, exposure was associated with a 57% higher risk.
The most telling result is the gap between those groups. The highest-risk veterans served in the Army Chemical Corps or in the Air Force's Operation Ranch Hand spraying missions, where handling the defoliant was part of the job. Risk that rises with the amount of exposure is one of the classic signs epidemiologists look for when judging whether an association might reflect a real effect. A flat result across all exposure levels would have been much easier to explain away.
Gregory Scott, a co-senior author, called this the first study in veterans to tie a higher Parkinson's risk to heavier Agent Orange exposure. Scott is an associate professor of pathology at the OHSU School of Medicine and a pathologist at the VA Portland. "We're catching up with history in a way," he said.
How the study was built, and what it can't prove
The researchers tracked diagnoses that appeared decades after the war, from 1999 through 2022. They compared those diagnoses with each veteran's level of exposure to the herbicide. They adjusted for factors that could muddy the picture, including traumatic brain injury and frailty.
This is an observational study, and that limits what it can show. OHSU's announcement describes it as definitively drawing the link, which overstates what a records review can establish. A study like this can show that exposure and diagnosis travel together in a very large population, and that the pattern strengthens with heavier exposure. It cannot by itself prove that the herbicide caused any individual veteran's disease. Exposure categories built from service records are also estimates. "Possible or presumed" exposure is a looser measure than a blood test or a documented spraying assignment.
The published summary also reports relative risk, not absolute risk. A 99% increase sounds alarming, but readers can't tell from the announcement how many veterans in each group were actually diagnosed. That number matters for anyone trying to understand their own odds. Parkinson's is common enough in older men that even a doubled relative risk still leaves most exposed veterans without the disease.
Even with those caveats, the scale is hard to dismiss. Few studies can follow millions of people across more than two decades of diagnoses, and the VA's records system makes that possible in a way few other health systems can match.
What it means for veterans and benefits
Agent Orange, a defoliant contaminated with dioxin, was used by the U.S. military to strip jungle cover during the Vietnam War. The Department of Veterans Affairs has for years treated Parkinson's disease as a condition presumed to be connected to Agent Orange exposure. Veterans with that diagnosis generally don't have to prove the herbicide caused their illness to receive benefits. The new study doesn't create that policy. It adds evidence beneath a presumption the government already made.
OHSU President Shereef Elnahal previously served as the VA's undersecretary of health. He pointed to the PACT Act of 2022, which extended health care benefits to veterans exposed to toxic substances such as Agent Orange and removed the burden of proof for veterans seeking care. He said the new findings show why that change mattered. "Veterans who put themselves in harm's way deserve to know the truth no matter how long it takes," he said.
The Lewy body dementia result may prove to be the more consequential finding over time. Parkinson's has dominated the public conversation about Agent Orange and the brain. A 66% higher risk of a related dementia suggests the herbicide's possible neurological effects reach beyond movement symptoms. That deserves follow-up research.
Co-author Lee Neilson is a neurologist who began the project at OHSU and has since moved to the University of Iowa. He said the findings confirm something many veterans have described for decades. "Veterans have been talking about this for years and years," Neilson said, adding that he expects veterans to feel validated and heard.
The study's reach goes beyond the Vietnam generation. Scott said the results should draw more attention to the long-term risks of prolonged contact with other chemical pesticides and herbicides. He said the research should push scientists to move faster and "not wait 50 years for the next herbicide to be linked to neurodegenerative disease." That may be the study's most practical lesson. The Agent Orange evidence took half a century to build because the diseases appear so long after exposure. Waiting for the same slow accumulation of diagnoses with newer chemicals would repeat the problem.
Other co-authors include Miranda Lim and Jonathan Elliott of OHSU and the VA Portland Health Care System. Lim is also affiliated with OHSU's Oregon Institute of Occupational Health Sciences.




